CAMK2G and metabolic dysfunction-associated steatotic liver disease: This work reveals that butyrate improves hepatic lipid metabolism through the GPR41/43‐CaMKII/HDAC1‐CREB pathway, providing support for consideration of butyrate as a dietary supplement to prevent the progression of NAFLD induced by the Western‐style diet.